Study title:
Gulati-S-C, Vega-R, Gee-T, et-al.
Department of Medicine and Pediatrics, Memorial Sloan-Kettering
Cancer Center, Cornell University Medical College, New York, NY 10021, United States.
Growth and development of children born to patients after cancer therapy.
Cancer Investigation {CANCER-INVEST}, 1986, Vol/Iss/Pg. 4/3 (197-205).Gulati-S-C, Vega-R, Gee-T, et-al.
Department of Medicine and Pediatrics, Memorial Sloan-Kettering
Cancer Center, Cornell University Medical College, New York, NY 10021, United States.
Growth and development of children born to patients after cancer therapy.
Cancer Investigation {CANCER-INVEST}, 1986, Vol/Iss/Pg. 4/3 (197-205).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|